Swiss National Bank Pfizer Inc Transaction History

Swiss National Bank

$140 Billion
Q1 2024

A detailed history of Swiss National Bank transactions in Pfizer Inc stock. As of the latest transaction made, Swiss National Bank holds 16,909,812 shares of PFE stock, worth $473 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

16,909,812

Previous 17,654,712 4.22%

Holding current value

$473 Million

Previous $508 Million 7.68%

% of portfolio

0.34%

Previous 0.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $19.3 Million - $22.1 Million	-744,900 Reduced 4.22%	16,909,812 $469 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $13.2 Million - $17.1 Million	-503,300 Reduced 2.77%	17,654,712 $508 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $71.5 Million - $83.6 Million	-2,227,700 Reduced 10.93%	18,158,012 $602 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $68.3 Million - $79 Million	-1,891,400 Reduced 8.49%	20,385,712 $748 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $21 Million - $27.3 Million	-533,000 Reduced 2.34%	22,277,112 $909 Million

Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $62.9 Million - $82.1 Million	-1,506,129 Reduced 6.19%	22,810,112 $1.17 Billion
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $3.38 Million - $4.12 Million	-77,200 Reduced 0.32%	24,316,241 $1.06 Billion
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $3.84 Million - $4.55 Million	82,500 Added 0.34%	24,393,441 $1.28 Billion
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $137 Million - $170 Million	3,000,100 Added 14.08%	24,310,941 $1.26 Billion
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $34 Million - $50.4 Million	-822,500 Reduced 3.72%	21,310,841 $1.26 Billion
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $23.9 Million - $30.8 Million	-610,000 Reduced 2.68%	22,133,341 $952 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $5.79 Million - $6.56 Million	-161,250 Reduced 0.7%	22,743,341 $891 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $13.7 Million - $15.5 Million	409,200 Added 1.82%	22,904,591 $830 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $20.3 Million - $25.8 Million	-605,600 Reduced 2.62%	22,495,391 $828 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $8.4 Million - $9.86 Million	-264,700 Reduced 1.13%	23,100,991 $848 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $9.86 Million - $12 Million	327,400 Added 1.42%	23,365,691 $764 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $108 Million - $154 Million	3,985,000 Added 20.92%	23,038,291 $752 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $34 Million - $38.6 Million	-1,032,000 Reduced 5.14%	19,053,291 $747 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $4.47 Million - $5.8 Million	137,702 Added 0.69%	20,085,291 $722 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $46 Million - $51.7 Million	-1,244,500 Reduced 5.87%	19,947,589 $864 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $10.9 Million - $12 Million	290,500 Added 1.39%	21,192,089 $900 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $13.2 Million - $15.1 Million	344,100 Added 1.67%	20,901,589 $912 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $36.7 Million - $44.6 Million	-1,065,900 Reduced 4.93%	20,557,489 $906 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $18.8 Million - $20.1 Million	570,300 Added 2.71%	21,623,389 $784 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $82.8 Million - $96 Million	-2,593,400 Reduced 10.97%	21,053,089 $747 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $452,336 - $479,944	13,600 Added 0.06%	23,646,489 $856 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $733 Million - $807 Million	23,632,889	23,632,889 $844 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Pfizer Inc Transaction History